— Know what they know.
Not Investment Advice

GOSS NASDAQ

Gossamer Bio, Inc.
1W: -39.1% 1M: -48.5% 3M: -90.6% YTD: -93.0% 1Y: -83.0% 3Y: -82.7% 5Y: -97.7%
$0.21
+0.01 (+4.58%)
 
Weekly Expected Move ±9.1%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 26 · $49.3M mcap · 195M float · 8.79% daily turnover · Short 69% of daily vol

📊 Key Metrics

TTM
$56M
Revenue
-55.4% YoY
$-180M
Net Income
-252.1% YoY
$-170M
Free Cash Flow
-514.2% YoY
98.6%
Gross Margin
-264.6%
Op. Margin
-275.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE386.8%
ROA-74.0%
ROIC244.7%

Valuation

P/E-0.3
P/B-0.3
EV/EBITDA-0.8

Leverage

Debt/Equity-1.65
Current Ratio2.64
Interest Cov.-15.5x

Quality Scores

Piotroski F1/9
Altman Z-13.76
Beneish M-1.43

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms